{"sha1": "6fdd3c7f9fee6e0346ca4d600fa7b0d22e713b14", "filename_exif": "4165.txt", "extension_exif": "TXT", "last_modified_exif": "2021:09:23 16:30:10+10:00", "create_date_exif": null, "access_date_exif": "2023:09:23 14:24:05+10:00", "modify_date_exif": "2021:09:23 16:30:10+10:00", "mime_type_exif": "text/plain", "file_size_exif": 8365, "title_exif": "", "path_components_exif": ["data", "medical_papers"], "publication_date_exif": "", "author_exif": "", "organizational_unit_exif": "", "content": "\n\n\n\n\n\n\n\n\n\n\u4f5c\u8005\u5355\u4f4d:350001\u798f\u5dde,\u798f\u5efa\u533b\u79d1\u5927\u5b66\u9644\u5c5e\u534f\u548c\u533b\u9662\u5fc3\u5916\u79d1(\u5218\u6d77\u6ce2\u3001\u9648\u826f\u4e07\u3001\u9648\u9053\u4e2d);\u798f\u5efa\u7701\u6cc9\u5dde\u5e02\u7b2c\u4e00\u533b\u9662\u5fc3\u5916\u79d1(\u5434\u4f1f\u5e73)\u5fc3\u810f\u79fb\u690d\u672f\u540e\u51a0\u72b6\u52a8\u8109\u75c5\u53d8\u7684\u76f8\u5173\u56e0\u7d20\u5206\u6790\u5218\u6d77\u6ce2\u5434\u4f1f\u5e73\u9648\u826f\u4e07\u9648\u9053\u4e2d\u3010\u6458\u8981\u3011\u76ee\u7684\u63a2\u8ba8\u5fc3\u810f\u79fb\u690d\u672f\u540e\u957f\u671f\u5b58\u6d3b\u7684\u60a3\u8005\u51a0\u72b6\u52a8\u8109\u75c5\u53d8\u7684\u76f8\u5173\u5371\u9669\u56e0\u7d20\u3002\u65b9\u6cd5\u56de\u987e\u6027\u5206\u679032\u4f8b\u5fc3\u810f\u79fb\u690d\u672f\u540e\u957f\u671f\u5b58\u6d3b\u60a3\u8005\u7684\u4e34\u5e8a\u8d44\u6599,\u5e76\u5bf9\u76f8\u5173\u7684\u4e34\u5e8a\u56e0\u7d20\u8fdb\u884c\u8bc4\u4ef7,\u7b5b\u9009\u51fa\u79fb\u690d\u5fc3\u51a0\u72b6\u52a8\u8109\u75c5\u53d8\u7684\u72ec\u7acb\u5371\u9669\u56e0\u7d20\u3002\u7ed3\u679c\u9ad8\u8102\u8840\u75c7\u3001\u70ed\u7f3a\u8840\u65f6\u95f4\u3001\u5de8\u7ec6\u80de\u75c5\u6bd2(CMV)\u6297\u4f53\u9633\u6027\u3001\u79fb\u690d\u540e\u65f6\u95f4\u53ca\u6162\u6027\u6392\u65a5\u53cd\u5e94\u662f\u79fb\u690d\u5fc3\u51a0\u72b6\u52a8\u8109\u75c5\u53d8\u7684\u5371\u9669\u56e0\u7d20,\u800c\u5e74\u9f84\u3001\u9ad8\u8840\u538b\u548c\u7cd6\u5c3f\u75c5\u4e0e\u79fb\u690d\u5fc3\u51a0\u72b6\u52a8\u8109\u75c5\u53d8\u7684\u76f8\u5173\u6027\u4e0d\u660e\u663e;\u591a\u5143Losgitic\u56de\u5f52\u5206\u6790,\u79fb\u690d\u540e\u65f6\u95f4\u548c\u6162\u6027\u6392\u65a5\u53cd\u5e94\u662f\u79fb\u690d\u5fc3\u51a0\u72b6\u52a8\u8109\u75c5\u53d8\u7684\u72ec\u7acb\u5371\u9669\u56e0\u7d20(P<0.001,P=0.003)\u3002\u7ed3\u8bba\u5fc3\u810f\u79fb\u690d\u672f\u540e\u51a0\u72b6\u52a8\u8109\u75c5\u53d8\u7684\u5b9e\u8d28\u662f\u6162\u6027\u6392\u65a5\u53cd\u5e94;\u4e0e\u4f9b\u5fc3\u7684\u70ed\u7f3a\u8840\u65f6\u95f4\u3001\u9ad8\u8102\u8840\u75c7\u53ca\u5de8\u7ec6\u80de\u75c5\u6bd2\u611f\u67d3\u7b49\u76f8\u5173\u3002\u3010\u5173\u952e\u8bcd\u3011\u5fc3\u810f\u79fb\u690d;\u51a0\u72b6\u52a8\u8109\u75be\u75c5;\u5371\u9669\u56e0\u7d20;\u7efc\u5408\u5206\u6790Relatedriskfactorofallograftcoronaryarterydiseaseafterhearttransplantation\uff0aLIUHai-bo,WUWei-ping,CHENLian-wang,etal.\uff0aDepartmentofCardiovascularSurgery,UnionHospitalofFujianMedicalUniversity,Fuzhou350001,China.\u3010Abstract\u3011ObjectiveToevaluatetherelatedriskfactorofallograftcoronaryarterydiseaseaf-terhearttransplantation.MethodsClinicaldataof32casesofcoronaryarterydiseaseafterhearttransplantationwerereviewed.UnivariateanalysisandmultivariateLogisticregressionanalysisweremadetoevaluatetheassociationoftheclinicalvariableswithCAV.ResultsHypercholesteremia,sur-vival,warmischemiatime,cytomegalovirusantibodypositivityandthegradeofchronicrejectionweretherelatedriskfactors(P<0.05).Age,hypertentionanddiabeteswerenotthecorrelatedriskfac-tors(P>0.05).MultivariablepredictorsofCAVincludedsurvival(P<0.001)andthegradeofchro-nicrejection(P=0.003).ConclusionsAllograftcoronaryarterydiseaseafterhearttransplantationisakindofchronicrejection.Itiscorrelatedwiththewarmischemiatime,cholesterol,cytomegalovirusinfection.\u3010Keywords\u3011Hearttransplantation;Coronarydisease;Riskfactors;Meta-analysis.\u5fc3\u810f\u79fb\u690d\u662f\u6cbb\u7597\u7ec8\u672b\u671f\u5fc3\u810f\u75c5\u7684\u6700\u6709\u6548\u65b9\u6cd5\u3002\u4f46\u5fc3\u810f\u79fb\u690d\u672f\u540e\u51a0\u72b6\u52a8\u8109\u75c5\u53d8(CAV)\u5df2\u6210\u4e3a\u9650\u5236\u60a3\u8005\u957f\u671f\u5b58\u6d3b\u7684\u4e3b\u8981\u56e0\u7d20[1]\u3002\u4e34\u5e8a\u4e0a\u5982\u4f55\u9884\u9632\u6216\u51cf\u7f13\u79fb\u690d\u5fc3\u51a0\u72b6\u52a8\u8109\u75c5\u53d8,\u5219\u662f\u5f53\u524d\u5668\u5b98\u79fb\u690d\u9886\u57df\u7684\u7814\u7a76\u91cd\u70b9\u3002\u6211\u4eec\u56de\u987e\u6027\u5206\u6790\u5fc3\u810f\u79fb\u690d\u672f\u540e\u957f\u671f\u5b58\u6d3b\u60a3\u8005\u5e76\u53d1\u51a0\u72b6\u52a8\u8109\u75c5\u53d8\u7684\u53d1\u751f\u7387,\u5e76\u5bf9\u76f8\u5173\u7684\u4e34\u5e8a\u56e0\u7d20\u8fdb\u884c\u8bc4\u4ef7,\u62a5\u544a\u5982\u4e0b\u3002\u6750\u6599\u4e0e\u65b9\u6cd51.\u4e00\u822c\u8d44\u6599:1995\u5e748\u6708\u81f32004\u5e746\u6708,\u672c\u9662\u6709\u5fc3\u810f\u79fb\u690d\u672f\u540e\u957f\u671f\u5b58\u6d3b\u60a3\u8005(>1\u5e74)32\u4f8b\u300232\u4f8b\u4e2d,\u7537\u602728\u4f8b,\u5973\u60274\u4f8b;\u5e74\u9f8423~56\u5c81;\u672f\u524d\u786e\u8bca\u4e3a\u6269\u5f20\u578b\u5fc3\u808c\u75c531\u4f8b,\u9057\u4f20\u6027\u80a5\u539a\u6897\u963b\u6027\u5fc3\u810f\u75c51\u4f8b\u3002\u63a5\u53d7\u540c\u79cd\u539f\u4f4d\u5fc3\u810f\u79fb\u690d\u672f\u540e\u5b58\u6d3b1.5~9\u5e74\u3002\u672f\u524d\u5e38\u89c4\u884c\u5b9e\u9a8c\u5ba4\u751f\u5316\u68c0\u67e5,\u5185\u5206\u6ccc\u5b66\u68c0\u67e5,\u76f8\u5173\u7ec6\u83cc\u5b66\u548c\u75c5\u6bd2\u5b66\u68c0\u67e5\u4ee5\u53ca\u5404\u79cd\u7269\u7406\u8f85\u52a9\u68c0\u67e5,\u5c24\u5176\u662fSwan-Ganz\u5bfc\u7ba1(\u6f02\u6d6e\u5bfc\u7ba1)\u68c0\u67e5,\u80ba\u8840\u7ba1\u963b\u529b(PVR)\u5e73\u5747\u4e3a(4.6\u00b11.8)dyn\u00b7L-1\u00b7min-1\u00b7(m2)-1\u3002\u4f9b\u8005\u5747\u4e3a\u7537\u6027\u8111\u6b7b\u4ea1\u8005,\u5e74\u9f8420~38\u5c81\u3002\u4f9b\u3001\u53d7\u8005\u95f4ABO\u8840\u578b\u4e00\u81f4\u3002\u70ed\u7f3a\u8840\u65f6\u95f43~14min,\u51b7\u7f3a\u8840\u65f6\u95f480~140min\u3002\u672f\u540e\u957f\u671f\u53e3\u670d\u73af\u5b62\u7d20A(CsA)\u3001\u6cfc\u5c3c\u677e(Pred)\u548c\u786b\u5511\u560c\u5464(Aza)\u4e09\u8054\u514d\u75ab\u6291\u5236\u5242;\u672f\u540e1~3\u4e2a\u6708\u73af\u5b62\u7d20A\u8840\u836f\u8c37\u503c\u6d53\u5ea6\u4e3a0.208~0.250\u03bcmol/L,4\u4e2a\u6708~1\u5e74\u4e3a0.166~0.208\u03bcmol/L,1\u5e74\u540e\u4e3a0.125~0.166\u03bcmol/L\u30022.\u89c2\u5bdf\u548c\u5206\u6790\u6307\u6807:(1)\u6709\u5426\u80f8\u95f7\u3001\u80f8\u75db\u3001\u5fc3\u60b8\u3001\u6c14\u4fc3\u3001\u809d\u5927\u3001\u53cc\u4e0b\u80a2\u6d6e\u80bf\u3001\u75b2\u4e4f\u3001\u7eb3\u5dee\u7b49\u4e34\u5e8a\u75c7\u72b6\u548c\u4f53\u5f81;(2)\u8840\u538b;(3)\u8840\u751f\u5316\u6307\u6807;(4)\u8840\u6e05\u5de8\u7ec6\u80de\u75c5\u6bd2\u6297\u4f53;(5)\u5fc3\u5185\u819c\u4e0b\u5fc3\u808c\u6d3b\u68c0;(6)SPECT99mTc-MI-\u00b7342\u00b7\u4e2d\u534e\u5668\u5b98\u79fb\u690d\u6742\u5fd72005\u5e746\u6708\u7b2c26\u5377\u7b2c6\u671fChinJOrganTransplant,Jun2005,Vol.26,No.6\ufffdBI\u9759\u606f\u5fc3\u808c\u704c\u6ce8\u65ad\u5c42\u663e\u50cf;(7)\u51a0\u72b6\u52a8\u8109\u9020\u5f71\u3002\u6839\u636e\u51a0\u72b6\u52a8\u8109\u9020\u5f71\u7ed3\u679c,\u5c06\u6b6432\u4f8b\u60a3\u8005\u5206\u4e3aCAV\u7ec4\u548c\u65e0CAV\u7ec4\u30023.\u7edf\u8ba1\u5b66\u5904\u7406:\u6240\u6709\u6570\u636e\u91c7\u7528SPSS11.5\u7edf\u8ba1\u8f6f\u4ef6\u5904\u7406\u3002\u8ba1\u91cf\u8d44\u6599\u7528\u5747\u6570\u00b1\u6807\u51c6\u5dee\u8868\u793a,\u91c7\u7528\u72ec\u7acb\u6837\u672c\u7684t\u68c0\u9a8c;\u8ba1\u6570\u8d44\u6599\u4ee5\u9891\u6570\u548c\u767e\u5206\u6570\u8868\u793a,\u5355\u56e0\u7d20\u5206\u6790\u7528\u03c72\u68c0\u9a8c\u3002\u5206\u522b\u4ee5\u5e74\u9f84\u3001\u6027\u522b\u3001\u70ed\u7f3a\u8840\u65f6\u95f4\u3001\u9ad8\u8840\u538b\u3001\u9ad8\u8840\u7cd6\u3001\u9ad8\u8840\u8102\u3001\u5438\u70df\u3001\u5de8\u7ec6\u80de\u75c5\u6bd2(CMV)\u6297\u4f53\u9633\u6027\u3001\u79fb\u690d\u540e\u65f6\u95f4\u53ca\u6392\u65a5\u53cd\u5e94\u4e3a\u81ea\u53d8\u91cf,\u4ee5\u6709\u65e0CAV\u4e3a\u56e0\u53d8\u91cf,\u91c7\u7528\u591a\u53d8\u91cf\u9010\u6b65Logis-tic\u56de\u5f52\u5206\u6790,\u8ba1\u7b97\u4e0eCAV\u76f8\u5173\u7684\u4e34\u5e8a\u53d8\u91cf\u3002\u7ed3\u679c1.\u4e00\u822c\u60c5\u51b5:\u672c\u7ec4\u60a3\u8005\u5fc3\u810f\u79fb\u690d\u672f\u540e\u751f\u6d3b\u8d28\u91cf\u5747\u826f\u597d,\u5df2\u6062\u590d\u6b63\u5e38\u5de5\u4f5c\u548c\u751f\u6d3b,\u65e0\u80f8\u95f7\u3001\u80f8\u75db\u3001\u5fc3\u60b8\u3001\u6c14\u4fc3\u3001\u809d\u5927\u3001\u53cc\u4e0b\u80a2\u6d6e\u80bf\u3001\u75b2\u4e4f\u3001\u7eb3\u5dee\u7b49\u4e34\u5e8a\u75c7\u72b6\u548c\u4f53\u5f81;\u9ad8\u8840\u538b2\u4f8b;\u8840\u80c6\u56fa\u9187\u5347\u9ad817\u4f8b;\u9ad8\u8840\u7cd63\u4f8b;\u5176\u4f59\u751f\u5316\u6307\u6807\u5747\u6b63\u5e38;\u8840\u6e05CMV\u6297\u4f53\u9633\u602717\u4f8b,\u9634\u602715\u4f8b;\u5fc3\u5185\u819c\u4e0b\u5fc3\u808c\u6d3b\u68c0\u793a\u8f7b\u5ea6\u6162\u6027\u6392\u65a5\u53cd\u5e9417\u4f8b,\u4e2d\u5ea6\u4ee5\u4e0a\u6162\u6027\u6392\u65a5\u53cd\u5e9415\u4f8b,\u5747\u672a\u89c1\u6025\u6027\u6392\u65a5\u53cd\u5e94;SPECT99mTC-MIBI\u9759\u606f\u5fc3\u808c\u704c\u6ce8\u65ad\u5c42\u663e\u50cf\u53d1\u73b0,\u5fc3\u808c\u8840\u6db2\u704c\u6ce8\u4e0d\u8db3\u8f7b\u5ea69\u4f8b,\u4e2d\u5ea68\u4f8b,\u91cd\u5ea69\u4f8b,\u6b63\u5e386\u4f8b;\u51a0\u72b6\u52a8\u8109\u9020\u5f71\u793a\u91cd\u5ea6\u5f25\u6f2b\u6027\u72ed\u7a848\u4f8b,\u4e2d\u5ea6\u5f25\u6f2b\u6027\u72ed\u7a845\u4f8b,\u5f25\u6f2b\u6027\u72ed\u7a842\u4f8b,\u6b63\u5e3817\u4f8b\u30022.\u76f8\u5173\u56e0\u7d20\u5206\u6790:\u5355\u56e0\u7d20\u5206\u6790\u8868\u660e,\u9ad8\u8102\u8840\u75c7\u3001CMV\u6297\u4f53\u9633\u6027\u3001\u70ed\u7f3a\u8840\u65f6\u95f4\u3001\u79fb\u690d\u540e\u65f6\u95f4\u53ca\u6162\u6027\u6392\u65a5\u53cd\u5e94\u662fCAV\u7684\u5371\u9669\u56e0\u7d20;\u800c\u5e74\u9f84\u3001\u7cd6\u5c3f\u75c5\u3001\u5438\u70df\u53ca\u9ad8\u8840\u538b\u4e0eCAV\u7684\u76f8\u5173\u6027\u4e0d\u660e\u663e(\u88681)\u3002\u5bf9\u4e0a\u8ff0\u5371\u9669\u56e0\u7d20\u8fdb\u4e00\u6b65\u884c\u591a\u5143Logistic\u56de\u5f52\u5206\u6790,\u7ed3\u679c\u8868\u660e\u4ec5\u79fb\u690d\u540e\u65f6\u95f4(P<0.001)\u548c\u6162\u6027\u6392\u65a5\u53cd\u5e94(P=0.003),\u662fCAV\u7684\u72ec\u7acb\u5371\u9669\u56e0\u7d20\u3002\u88681\u79fb\u690d\u5fc3\u51a0\u72b6\u52a8\u8109\u75c5\u53d8\u7684\u5371\u9669\u56e0\u7d20\u5206\u6790\u5371\u9669\u56e0\u7d20CAV\u7ec4(15\u4f8b)\u65e0CAV\u7ec4(17\u4f8b)\u5e74\u9f84(\u5c81)39.5\u00b115.837.2\u00b114.4\u9ad8\u8840\u538b(\u4f8b)1(6%)1(6%)\u9ad8\u8102\u8840\u75c7(\u4f8b)14(93%)3(18%)\uff0a\u7cd6\u5c3f\u75c5(\u4f8b)1(6%)2(12%)CMV\u6297\u4f53\u9633\u6027(\u4f8b)13(87%)4(24%)\uff0a\u5438\u70df(\u4f8b)2(13%)3(18%)\u70ed\u7f3a\u8840\u65f6\u95f4(min)12.5\u00b11.33.7\u00b11.2\uff0a\u6162\u6027\u6392\u65a5\u53cd\u5e94(\u4f8b)15(100%)0(0%)\uff0a\u79fb\u690d\u540e\u65f6\u95f4(\u6708)85.3\u00b112.121.5\u00b17.6\uff0a\u6ce8:\u4e0eCAV\u7ec4\u6bd4\u8f83,\uff0aP<0.05\u8ba8\u8bba\u5173\u4e8eCAV\u7684\u76f8\u5173\u56e0\u7d20\u7814\u7a76,\u56fd\u5185\u5916\u5c1a\u65e0\u5b8c\u6574\u7684\u5927\u6837\u672c\u7814\u7a76\u7ed3\u679c\u3002\u76ee\u524d\u8ba4\u4e3a,\u4e3b\u8981\u7531\u514d\u75ab\u56e0\u7d20\u4ecb\u5bfc\u7684\u3001\u975e\u514d\u75ab\u56e0\u7d20\u53c2\u4e0e\u3001\u53cd\u590d\u7684\u8840\u7ba1\u5185\u76ae\u635f\u4f24\u4fee\u590d\u53cd\u5e94\u548c\u8840\u7ba1\u518d\u5851\u5f62,\u5bfc\u81f4\u4e86\u8840\u7ba1\u72ed\u7a84\u548c\u95ed\u585e[2]\u3002\u6211\u4eec\u7684\u75c5\u4f8b\u7814\u7a76\u4e2d,\u79fb\u690d\u5fc3\u51a0\u72b6\u52a8\u8109\u75c5\u53d8(CAV)\u7684\u53d1\u751f\u7387\u4e3a47%,\u5355\u56e0\u7d20\u5206\u6790\u8868\u660e,\u9ad8\u8102\u8840\u75c7\u3001\u70ed\u7f3a\u8840\u65f6\u95f4\u3001CMV\u6297\u4f53\u9633\u6027\u3001\u79fb\u690d\u540e\u65f6\u95f4\u548c\u6162\u6027\u6392\u65a5\u53cd\u5e94\u662fCAV\u7684\u5371\u9669\u56e0\u7d20,\u8fd9\u4e0e\u6587\u732e\u62a5\u9053\u4e00\u81f4[3,4],\u800c\u5e74\u9f84\u3001\u5438\u70df\u3001\u9ad8\u8840\u538b\u548c\u7cd6\u5c3f\u75c5\u4e0eCAV\u65e0\u660e\u663e\u7684\u76f8\u5173\u6027\u3002\u6211\u4eec\u7684\u5206\u6790\u7ed3\u679c\u63d0\u793a:(1)\u7ec6\u80de\u6027\u514d\u75ab\u6392\u65a5\u53cd\u5e94\u53ef\u80fd\u4e0d\u662f\u5bfc\u81f4\u51a0\u72b6\u52a8\u8109\u75c5\u53d8\u7684\u4e3b\u8981\u539f\u56e0,\u800c\u662f\u7531\u6162\u6027\u6392\u65a5\u53cd\u5e94\u5f15\u8d77\u7684\u3002(2)\u4f9b\u5fc3\u6458\u53d6\u65f6\u5e94\u5c3d\u91cf\u7f29\u77ed\u70ed\u7f3a\u8840\u65f6\u95f4,\u4ee5\u514d\u52a0\u5267\u7f3a\u8840\u518d\u704c\u6ce8\u635f\u4f24,\u7834\u574f\u5185\u76ae\u7ec6\u80de\u529f\u80fd\u3002(3)\u867d\u7136\u5fc3\u810f\u79fb\u690d\u672f\u540e\u51a0\u72b6\u52a8\u8109\u75c5\u53d8\u4e0e\u81ea\u7136\u4eba\u7fa4\u51a0\u72b6\u52a8\u8109\u7ca5\u6837\u786c\u5316\u75c5\u7406\u6539\u53d8\u76f8\u4f3c,\u4f46\u81ea\u7136\u4eba\u7fa4\u51a0\u72b6\u52a8\u8109\u7ca5\u6837\u786c\u5316\u7684\u67d0\u4e9b\u6613\u611f\u56e0\u7d20\u5982\u9ad8\u8840\u538b\u3001\u7cd6\u5c3f\u75c5\u3001\u5438\u70df\u8fd8\u96be\u4ee5\u89e3\u91ca\u5fc3\u810f\u79fb\u690d\u672f\u540e\u51a0\u72b6\u52a8\u8109\u75c5\u53d8\u7684\u53d1\u751f\u3002\u591a\u5143Logistic\u56de\u5f52\u5206\u6790\u8868\u660e,\u4ec5\u79fb\u690d\u540e\u65f6\u95f4\u548c\u6162\u6027\u6392\u65a5\u53cd\u5e94\u662fCAV\u7684\u72ec\u7acb\u5371\u9669\u56e0\u7d20,\u56e0\u6b64\u65e9\u671f\u8bca\u65adCAV\u6781\u4e3a\u91cd\u8981\u3002\u4e00\u65e6\u53d1\u751f\u79fb\u690d\u5fc3\u51a0\u72b6\u52a8\u8109\u75c5\u53d8,\u9884\u540e\u4e0d\u5bb9\u4e50\u89c2,\u5173\u952e\u5728\u4e8e\u9884\u9632[5]\u3002\u51a0\u72b6\u52a8\u8109\u9020\u5f71\u867d\u7136\u662f\u8bca\u65ad\u51a0\u72b6\u52a8\u8109\u75c5\u53d8\u7684\u91d1\u6807\u51c6,\u4f46\u5c5e\u6709\u521b\u68c0\u67e5,\u4ef7\u683c\u6602\u8d35,\u53cd\u590d\u68c0\u67e5\u4e0d\u4e3a\u60a3\u8005\u63a5\u53d7\u3002\u672c\u7ec4\u540c\u4f4d\u7d20\u5fc3\u808c\u704c\u6ce8\u663e\u50cf\u7ed3\u679c\u4e0e\u51a0\u72b6\u52a8\u8109\u9020\u5f71\u7ed3\u679c\u76f8\u7b26,\u8bf4\u660e\u672c\u7ec4\u75c5\u4f8b\u4e2d\u540c\u4f4d\u7d20\u5fc3\u808c\u704c\u6ce8\u663e\u50cf\u6709\u4e00\u5b9a\u7684\u8f85\u52a9\u8bca\u65ad\u4ef7\u503c\u3002\u56e0\u6b64,\u6211\u4eec\u8ba4\u4e3a,\u5bf9\u5fc3\u810f\u79fb\u690d\u672f\u540e\u957f\u671f\u5b58\u6d3b\u7684\u60a3\u8005,\u8fd9\u4e24\u79cd\u65b9\u6cd5\u53ef\u5217\u4e3a\u5e38\u89c4\u68c0\u67e5\u9879\u76ee\u3002\u53c2\u8003\u6587\u732e1\u8d75\u7edf\u5175.\u4f9b\u4f53\u5fc3\u810f\u51a0\u72b6\u52a8\u8109\u589e\u6b96\u6027\u5fc3\u810f\u75c5.\u89c1:\u590f\u6c42\u660e,\u4e3b\u7f16.\u73b0\u4ee3\u5fc3\u810f\u79fb\u690d.\u5317\u4eac:\u4eba\u6c11\u536b\u751f\u51fa\u7248\u793e,1998.229-240.2VicensM,IsabelR,RosaA,etal.Coronaryendothehaldys-functionasapredictorofintimalthickeninginthelongtermafterhearttransplantation.JThoracCardiovascSurg,2001,122:1174-1180.3\u80e1\u76db\u5bff,\u9ec4\u65b9\u70af.\u51a0\u5fc3\u75c5\u7684\u5916\u79d1\u6cbb\u7597\u5b66.\u7b2c1\u7248.\u5317\u4eac:\u79d1\u5b66\u51fa\u7248\u793e,2003.13-14.4KoskinenPK,KallioEA,TikkanenJM,etal.Cytomegalovirusinfectionandcardiacallograftvasculopathy.TransplInfectDis,1999,1:115-126.5ArandaJM,HillJ,HoytG,etal.Cardiactransplantvasculopa-thy.Chest,2000,118:1792-1800.(\u6536\u7a3f\u65e5\u671f:2004-08-23)\u00b7343\u00b7\u4e2d\u534e\u5668\u5b98\u79fb\u690d\u6742\u5fd72005\u5e746\u6708\u7b2c26\u5377\u7b2c6\u671fChinJOrganTransplant,Jun2005,Vol.26,No.6\ufffd\n\n"}